Identification and validation of molecular subtypes' characteristics in bladder urothelial carcinoma based on autophagy-dependent ferroptosis

被引:2
|
作者
Liu, Shiwei [1 ,4 ,5 ]
Zhai, Jing [2 ]
Li, Deng [1 ]
Peng, Yu [2 ]
Wang, Yi [1 ,3 ,8 ]
Dai, Bo [4 ,5 ,6 ,7 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200032, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Urol, Shanghai 200080, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Inst Integrat Med, Shanghai 200437, Peoples R China
[4] Nantong Univ, Dept Urol, Affiliated Hosp, Nantong 226001, Jiangsu Provinc, Peoples R China
[5] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[6] Shanghai Genitourinary Canc Inst, Shanghai 200032, Peoples R China
[7] Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dongan Rd, Shanghai 200032, Peoples R China
[8] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Urol, Sch Med, 85 Wujin Rd, Shanghai 200080, Peoples R China
关键词
Autophagy-dependent ferroptosis; Bladder urothelial carcinoma; Immunotherapy; Prognosis; IMMUNE-RELATED GENES; TUMOR MICROENVIRONMENT; CANCER STATISTICS; PROFILES;
D O I
10.1016/j.heliyon.2023.e21092
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Nowadays, more evidences indicated that autophagy-dependent ferroptosis regulatory molecules (ADFRMs) may be closely related to various tumors. In current study, we intended to establish a prognostic ADFRMs signature and investigated its potential roles in bladder urothelial carcinoma (BLCA).Methods: Two distinct clusters were determined by consensus clustering with expression of 119 identified ADFRMs in BLCA. The tumor microenvironment was investigated through "CIBER-SORT" algorithm, and enrichment analyses were utilized to seek molecular characteristics of differentially expressed genes (DEGs) between clusters. Moreover, a 2-ADFRMs prognostic signature including TRIB3 and WIPI1 was identified in TCGA cohort and further evaluated in the GSE13507 cohort. The qRT-PCR was conducted to examine the expression of prognostic genes. Further, the risk score was gained through calculating the level of TRIB3 and WIPI1 expression through the coefficient. The correlations between risk score with clinicopathologica features, tumor microenvironment, and drug sensitivity were explored.Results: Patients in TCGA-BLCA were grouped into two clusters with different expression patterns of ADFRMs. And the overall survival, tumor microenvironment and biological functions were significant different between two clusters. Moreover, a 2-ADFRMs model was constructed, and patients were separated into a low-risk and high-risk group. Survival analysis indicated patients with low risk promised a good prognosis, suggesting the risk score determined with ADFRMs signature exhibited an acceptable capacity for survival prediction in BLCA. Correlation analysis
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Identification of Molecular Subtypes and a Novel Prognostic Model of Sepsis Based on Ferroptosis-Associated Gene Signature
    Yang, Hang
    Cui, Yanhui
    Peng, Wenzhong
    Zhu, Fei
    Ma, Shiyang
    Rao, Mingjun
    Zhang, Peipei
    Chen, Jie
    Pan, Pinhua
    BIOMOLECULES, 2022, 12 (10)
  • [32] Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes
    Li, Huili
    Zhang, Qingzhao
    Shuman, Lauren
    Kaag, Matthew
    Raman, Jay D.
    Merrill, Suzanne
    DeGraff, David J.
    Warrick, Joshua, I
    Chen, Guoli
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [33] Evaluation of PD-L1 and Other Immune Markers in Bladder Urothelial Carcinoma Stratified by Histologic Variants and Molecular Subtypes
    Li, Huili
    Zhang, Qingzhao
    Shuman, Lauren
    Kaag, Matthew
    Raman, Jay
    Merrill, Suzanne
    DeGraff, David
    Warrick, Joshua
    Chen, Guoli
    MODERN PATHOLOGY, 2019, 32
  • [34] Evaluation of PD-L1 and Other Immune Markers in Bladder Urothelial Carcinoma Stratified by Histologic Variants and Molecular Subtypes
    Li, Huili
    Zhang, Qingzhao
    Shuman, Lauren
    Kaag, Matthew
    Raman, Jay
    Merrill, Suzanne
    DeGraff, David
    Warrick, Joshua
    Chen, Guoli
    LABORATORY INVESTIGATION, 2019, 99
  • [35] Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes
    Huili Li
    Qingzhao Zhang
    Lauren Shuman
    Matthew Kaag
    Jay D. Raman
    Suzanne Merrill
    David J. DeGraff
    Joshua I. Warrick
    Guoli Chen
    Scientific Reports, 10
  • [36] Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs
    Lin, Hongsheng
    Xie, Yangyi
    Kong, Yinzhi
    Yang, Li
    Li, Mingfen
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [37] Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis
    Lopez-Beltran, Antonio
    Blanca, Ana
    Cimadamore, Alessia
    Gogna, Rajan
    Montironi, Rodolfo
    Cheng, Liang
    CANCERS, 2021, 13 (21)
  • [38] Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation
    Yu, Yang
    Huang, Yuexi
    Li, Chen
    Ou, Santao
    Xu, Chaojie
    Kang, Zhengjun
    FRONTIERS IN GENETICS, 2022, 13
  • [39] Identification and Validation of Immune Molecular Subtypes and Immune Landscape Based on Colon Cancer Cohort
    Qi, Wenqian
    Zhang, Qian
    FRONTIERS IN MEDICINE, 2022, 9
  • [40] Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy
    Olah, Csilla
    Shmorhun, Oleksandr
    Klamminger, Gilbert Georg
    Rawitzer, Josefine
    Sichward, Lara
    Hadaschik, Boris
    Al-Nader, Mulham
    Krafft, Ulrich
    Niedworok, Christian
    Varadi, Melinda
    Nyirady, Peter
    Kiss, Andras
    Szekely, Eszter
    Reis, Henning
    Szarvas, Tibor
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2025, 11 (01):